ImmunologybioRxivPreprint
Genome editing human primary T cells with microfluidic vortex shedding & CRISPR Cas9
J. A. Jarrell, B. J. Sytsma, L. H. Wilson…·R. S. Pawell
This study evaluates microfluidic vortex shedding (VS) and electric field-enhanced VS (eVS) for delivering CRISPR-Cas9 RNP to primary human T cells, showing improved editing efficiency and cell viability compared to electroporation.
DOI 10.1101/2020.02.26.960336